Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Bath & Body Works Shares Hit New Low as Analyst Sentiment Sours

Felix Baarz by Felix Baarz
October 31, 2025
in Analysis, Consumer & Luxury
0
Bath & Body Works Stock
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Bath & Body Works shares have extended their decline, reaching a fresh 52-week low during Wednesday’s trading session. The stock closed at $24.82 after declining 4.9% for the day, signaling continued downward momentum that has investors concerned about when the slide might stabilize.

Financial Performance Metrics

While the company met expectations in its most recent quarterly report with earnings per share of $0.37 and revenue of $1.55 billion, deeper examination reveals underlying challenges. Revenue showed a year-over-year contraction of 0.8%, indicating potential headwinds for the business. The stock’s current trading position below key technical indicators—$27.35 for the 50-day moving average and $29.04 for the 200-day moving average—further underscores the negative trend. Even with a price-to-earnings ratio of 7.37 and market capitalization of $5.12 billion, investors remain cautious.

Analyst Downgrades and Price Target Cuts

Market analysts have responded to the deteriorating situation with significant adjustments to their assessments:

Should investors sell immediately? Or is it worth buying Bath & Body Works?

  • Jefferies Financial Group reduced its price target from $32.00 to $28.50 back in October
  • Wells Fargo & Company implemented a more substantial cut, lowering their target from $44.00 to $33.00
  • Wall Street Zen downgraded its rating from “Buy” to “Hold”

Analysts point to inconsistent product launches and mounting margin pressure as primary factors behind these revised outlooks.

Institutional Stance Amid Retail Exodus

As retail investors reduce their exposure, Victory Capital Management maintains its substantial position in the company. The investment firm holds 8.4 million shares, representing 4.08% of outstanding equity, and retains both voting and disposal rights. This institutional commitment raises questions about whether such support can potentially counterbalance the current negative momentum.

Market Context and Recent Performance

The broader consumer goods sector appears to be facing increasing headwinds, contributing to the challenging environment for Bath & Body Works. Recent trading patterns show the stock has declined in six of the last ten sessions, resulting in a cumulative loss of 8.0% over that period. With the stock establishing a new 52-week low at $24.84 during Wednesday’s session, market participants are watching closely for any signs of stabilization or reversal in the current trend.

Ad

Bath & Body Works Stock: Buy or Sell?! New Bath & Body Works Analysis from February 7 delivers the answer:

The latest Bath & Body Works figures speak for themselves: Urgent action needed for Bath & Body Works investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Bath & Body Works: Buy or sell? Read more here...

Tags: Bath & Body Works
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

CrossFirst Bankshares Stock
Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
Riley Exploration Permian Stock
Analysis

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

February 7, 2026
Next Post
CSG Stock

Acquisition Deal Propels CSG Shares to Multi-Year High

Kinder Morgan Stock

Kinder Morgan Shares Hold Steady Amid Regulatory Review

Century Communities Stock

Century Communities Stock Surges on Exceptional Quarterly Performance

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com